139 related articles for article (PubMed ID: 25845528)
21. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
23. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis.
Oei AL; van Leeuwen CM; ten Cate R; Rodermond HM; Buist MR; Stalpers LJ; Crezee J; Kok HP; Medema JP; Franken NA
Cancer Res; 2015 Dec; 75(23):5120-9. PubMed ID: 26573798
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
25. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
26. Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma.
Lee E; Lee BB; Ko E; Kim Y; Han J; Shim YM; Park J; Kim DH
Cancer; 2013 May; 119(9):1752-60. PubMed ID: 23310950
[TBL] [Abstract][Full Text] [Related]
27. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.
Murray PG; Fan Y; Davies G; Ying J; Geng H; Ng KM; Li H; Gao Z; Wei W; Bose S; Anderton J; Kapatai G; Reynolds G; Ito A; Marafioti T; Woodman CB; Ambinder R; Tao Q
Am J Pathol; 2010 Sep; 177(3):1480-90. PubMed ID: 20709797
[TBL] [Abstract][Full Text] [Related]
30. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
[TBL] [Abstract][Full Text] [Related]
31. CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.
Vallath S; Sage EK; Kolluri KK; Lourenco SN; Teixeira VS; Chimalapati S; George PJ; Janes SM; Giangreco A
Sci Rep; 2016 Apr; 6():24006. PubMed ID: 27035095
[TBL] [Abstract][Full Text] [Related]
32. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
Henken FE; Wilting SM; Overmeer RM; van Rietschoten JG; Nygren AO; Errami A; Schouten JP; Meijer CJ; Snijders PJ; Steenbergen RD
Br J Cancer; 2007 Nov; 97(10):1457-64. PubMed ID: 17971771
[TBL] [Abstract][Full Text] [Related]
33. Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis.
de Wilde J; De-Castro Arce J; Snijders PJ; Meijer CJ; Rösl F; Steenbergen RD
Cell Oncol; 2008; 30(1):77-87. PubMed ID: 18219112
[TBL] [Abstract][Full Text] [Related]
34. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by γ-secretase complex.
Nagara Y; Hagiyama M; Hatano N; Futai E; Suo S; Takaoka Y; Murakami Y; Ito A; Ishiura S
Biochem Biophys Res Commun; 2012 Jan; 417(1):462-7. PubMed ID: 22172944
[TBL] [Abstract][Full Text] [Related]
36. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
37. miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling.
Momose K; Minami A; Shimono Y; Mizutani K; Nobutani K; Azuma T; Takai Y
Genes Cells; 2013 Mar; 18(3):195-202. PubMed ID: 23301758
[TBL] [Abstract][Full Text] [Related]
38. Dissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene Cadm1.
Reamon-Buettner SM; Borlak J
PLoS One; 2012; 7(6):e38531. PubMed ID: 22701659
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
van den Berg RM; Snijders PJ; Grünberg K; Kooi C; Spreeuwenberg MD; Meijer CJ; Postmus PE; Smit EF; Steenbergen RD
Lung Cancer; 2011 Jun; 72(3):316-21. PubMed ID: 21067843
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
